MEM
MEMPHASYS FPO [MEM]
Healthcare · ASX Small Cap
$0.0060 +20.0%
Updated 3 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when MEM triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Volume surging at 17.5x normal while price falls — heavy selling pressure
- On a tear — up 20.0% over the last 5 days
- Volume-price trend suggests distribution — sellers may be sneaking out while price holds
- Trading above the 200-day average — the long-term trend is on your side
- Critical cash runway (0.6 quarters)
- Very high P/S ratio (86.6x)
- Revenue in sharp decline (-96%)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- Positive long-term momentum — up 50% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (1.59%/day)
- Altman Z-Score grey zone (2.03, low-confidence approx)
- Penny stock risk ($0.006)
- RBA hiking (-3pts)
Risk Signals
- Piotroski F-Score weak (2/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -96% — the top line is shrinking
Ask Scout AI about MEM
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Felix Registration Achieved in Turkey, Sales Commence
NONE Notification of cessation of securities - MEM
NONE EUR526,500 Nordic Agreement Expands Felix European Footprint
LOW Appendix 4E and 2026 Annual Report
Recent ASX Announcements
| 2026-09-02 | Felix Registration Achieved in Turkey, Sales Commence PRICE SENSITIVE |
| 2026-09-01 | Notification of cessation of securities - MEM |
| 2026-08-31 | EUR526,500 Nordic Agreement Expands Felix European Footprint PRICE SENSITIVE |
| 2026-08-31 | Appendix 4G and Corporate Governance Statement |
| 2026-08-31 | Appendix 4E and 2026 Annual Report PRICE SENSITIVE |
Key Metrics
$18.5M
Market Cap
5.4M
Avg Volume
17.5x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-87.4%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 53% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
113 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track MEM and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required